ICD-10: T75.23

Clinical Description of ICD-10 Code T75.23: Vertigo from Infrasound

ICD-10 code T75.23 specifically refers to vertigo that arises from exposure to infrasound. Infrasound is defined as sound waves with frequencies below the lower limit of human audibility, typically below 20 Hz. While humans cannot consciously hear these low-frequency sounds, they can still have physiological effects, including the potential to induce vertigo.

Understanding Infrasound

Infrasound is produced by various natural and artificial sources, including:

• Natural Sources: Earthquakes, volcanic eruptions, ocean waves, and wind.
• Artificial Sources: Machinery, transportation systems (like trains and airplanes), and industrial processes.

The impact of infrasound on human health is an area of ongoing research. Some studies suggest that prolonged exposure to infrasound can lead to various symptoms, including:

• Dizziness: A sensation of spinning or loss of balance, which is classified as vertigo.
• Nausea: Feelings of sickness that may accompany dizziness.
• Disorientation: Difficulty in maintaining spatial orientation.

Clinical Presentation

Patients experiencing vertigo from infrasound may present with the following symptoms:

• Spinning Sensation: A hallmark of vertigo, where the individual feels as if they or their surroundings are moving.
• Balance Issues: Difficulty in maintaining stability, which can increase the risk of falls.
• Accompanying Symptoms: These may include tinnitus (ringing in the ears), headache, or a sense of pressure in the ears.

Diagnosis and Management

Diagnosing vertigo from infrasound involves a thorough clinical history and examination. Key steps include:

1. Patient History: Assessing exposure to infrasound sources and the onset of symptoms.
2. Physical Examination: Evaluating balance and coordination.
3. Diagnostic Tests: These may include audiometric testing and vestibular function tests to rule out other causes of vertigo.

Management typically focuses on:

• Avoidance of Infrasound Exposure: Reducing or eliminating exposure to identified sources of infrasound.
• Symptomatic Treatment: Medications such as antihistamines or vestibular suppressants may be prescribed to alleviate symptoms.

Conclusion

ICD-10 code T75.23 is crucial for accurately documenting cases of vertigo attributed to infrasound exposure. Understanding the clinical implications and management strategies for this condition is essential for healthcare providers, particularly in environments where infrasound exposure is prevalent. As research continues, further insights into the effects of infrasound on health will enhance diagnostic and therapeutic approaches.

The ICD-10-CM code T75.23 specifically refers to "Vertigo from infrasound," which is a condition that can arise from exposure to low-frequency sounds that are below the threshold of human hearing. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with this condition is crucial for accurate diagnosis and management.

Clinical Presentation

Definition of Infrasound

Infrasound refers to sound waves with frequencies below 20 Hz, which are typically inaudible to the human ear. Sources of infrasound can include natural phenomena (like earthquakes and volcanic eruptions) and man-made sources (such as wind turbines, heavy machinery, and certain types of transportation) [9][10].

Symptoms of Vertigo from Infrasound

Patients experiencing vertigo from infrasound may present with a variety of symptoms, including:

• Dizziness: A sensation of spinning or movement, which can be disorienting and distressing.
• Balance Issues: Difficulty maintaining balance, leading to an increased risk of falls.
• Nausea: Some patients may experience nausea or even vomiting as a result of the vertigo.
• Tinnitus: Ringing or buzzing in the ears may accompany the vertigo, particularly in cases of prolonged exposure to infrasound.
• Headaches: Patients may report headaches, which can be exacerbated by the vertiginous sensations.
• Fatigue: Chronic exposure to infrasound can lead to fatigue and a general sense of malaise [3][4][9].

Signs

During a clinical examination, healthcare providers may observe:

• Nystagmus: Involuntary eye movements that can occur during episodes of vertigo.
• Postural Instability: Difficulty in maintaining a stable posture, which may be evident during balance tests.
• Altered Gait: Patients may exhibit an unsteady gait when walking, particularly in environments with persistent infrasound exposure [2][3].

Patient Characteristics

Demographics

• Age: While vertigo can affect individuals of all ages, certain populations, such as older adults, may be more susceptible due to age-related vestibular decline.
• Occupational Exposure: Individuals working in environments with high levels of infrasound (e.g., near wind turbines, heavy machinery) may be at greater risk for developing symptoms related to infrasound exposure [9][10].

Health History

• Pre-existing Conditions: Patients with a history of vestibular disorders, migraines, or other neurological conditions may be more prone to experiencing vertigo from infrasound.
• Environmental Factors: A history of living or working in areas with significant infrasound exposure can be a critical factor in the clinical assessment [4][9].

Psychological Impact

• Anxiety and Stress: The experience of vertigo can lead to increased anxiety and stress, which may exacerbate symptoms. Patients may also develop a fear of situations where vertigo could occur, impacting their quality of life [3][4].

Conclusion

Vertigo from infrasound, classified under ICD-10 code T75.23, presents a unique set of challenges for both patients and healthcare providers. Recognizing the symptoms, signs, and patient characteristics associated with this condition is essential for effective diagnosis and management. As awareness of the effects of infrasound grows, particularly in occupational health contexts, further research and clinical attention will be necessary to address the needs of affected individuals.

When discussing the ICD-10-CM code T75.23, which specifically refers to "Vertigo from infrasound," it is helpful to explore alternative names and related terms that may be used in medical contexts. Understanding these terms can enhance clarity in communication among healthcare professionals and improve patient education.

Alternative Names for T75.23

1. Infrasound-Induced Vertigo: This term emphasizes the cause of the vertigo, linking it directly to exposure to infrasound frequencies, which are sound waves below the audible range (typically below 20 Hz).

2. Low-Frequency Vertigo: This alternative name highlights the frequency aspect of infrasound, indicating that the vertigo is associated with low-frequency sound waves.

3. Environmental Vertigo: In some contexts, this term may be used to describe vertigo resulting from environmental factors, including exposure to infrasound.

4. Acoustic Vertigo: This term can refer to vertigo caused by sound exposure, including infrasound, although it is broader and may encompass other types of sound-related vertigo.

Related Terms

1. Dizziness: While not specific to infrasound, dizziness is a broader term that encompasses various sensations, including vertigo. The ICD-10 code R42 is often used for dizziness and giddiness, which may be related to T75.23 in cases where infrasound exposure is a factor.

2. Vestibular Disorders: This term refers to a range of conditions affecting the vestibular system, which is responsible for balance. Vertigo from infrasound can be considered a specific type of vestibular disorder.

3. Sound-Induced Illness: This broader category may include various health effects caused by sound exposure, including vertigo, and can encompass infrasound-related conditions.

4. Acoustic Trauma: Although typically associated with damage from loud sounds, this term can sometimes be used in discussions about the effects of sound on health, including vertigo.

5. Tinnitus: While primarily characterized by ringing in the ears, tinnitus can sometimes accompany vertigo, especially in cases of sound exposure, including infrasound.

Conclusion

Understanding the alternative names and related terms for ICD-10 code T75.23 is essential for effective communication in medical settings. These terms not only clarify the specific condition but also help in discussing broader implications related to sound exposure and its effects on health. If you have further questions or need additional information on this topic, feel free to ask!

The diagnosis of vertigo from infrasound, classified under ICD-10-CM code T75.23, involves specific criteria that healthcare professionals utilize to identify and confirm the condition. Here’s a detailed overview of the diagnostic criteria and considerations associated with this code.

Understanding Infrasound and Its Effects

Infrasound refers to sound waves with frequencies below the lower limit of human audibility, typically below 20 Hz. While these sounds are not consciously heard, they can still affect the human body, potentially leading to various health issues, including vertigo.

Diagnostic Criteria for T75.23

1. Clinical Symptoms:
   - Patients typically present with symptoms of vertigo, which may include a sensation of spinning or dizziness. This can be accompanied by nausea, balance disturbances, and other vestibular symptoms.
   - The onset of symptoms should correlate with exposure to infrasound sources, such as wind turbines, heavy machinery, or natural phenomena.

2. Exposure History:
   - A thorough history of exposure to infrasound is crucial. This includes identifying the duration, intensity, and frequency of exposure to infrasound sources.
   - Patients should report any correlation between their symptoms and specific activities or environments where infrasound is prevalent.

3. Exclusion of Other Causes:
   - It is essential to rule out other potential causes of vertigo, such as inner ear disorders, neurological conditions, or other environmental factors. This may involve:

   • Audiometric testing to assess hearing function.
   • Imaging studies (e.g., MRI or CT scans) to exclude structural abnormalities.
   • Balance assessments to evaluate vestibular function.

4. Diagnostic Tests:
   - While there are no specific tests for diagnosing vertigo from infrasound, healthcare providers may use various assessments to evaluate the vestibular system and overall balance.
   - Tests may include the Dix-Hallpike maneuver, caloric testing, or posturography to assess the patient's balance and vestibular function.

5. Patient Reporting:
   - Patient-reported outcomes are vital in diagnosing this condition. Clinicians may use questionnaires or scales to quantify the severity and impact of vertigo on the patient's daily life.

Conclusion

Diagnosing vertigo from infrasound (ICD-10 code T75.23) requires a comprehensive approach that includes evaluating clinical symptoms, exposure history, and ruling out other potential causes. Given the unique nature of infrasound and its effects on health, a thorough understanding of the patient's environment and experiences is essential for accurate diagnosis and subsequent management. If you suspect infrasound exposure is affecting your health, consulting a healthcare professional for a detailed evaluation is advisable.

When addressing the treatment approaches for vertigo associated with infrasound, classified under ICD-10 code T75.23, it is essential to understand both the nature of infrasound and the general management strategies for vertigo.

Understanding Infrasound and Its Effects

Infrasound refers to sound waves with frequencies below the lower limit of human hearing, typically below 20 Hz. While infrasound is often produced by natural phenomena (like earthquakes and volcanic eruptions) and human activities (such as traffic and industrial processes), its effects on human health, particularly in relation to vertigo, are still being studied. Some individuals may experience symptoms such as dizziness, nausea, and disorientation when exposed to infrasound, leading to the diagnosis of vertigo from infrasound exposure[1].

Standard Treatment Approaches

1. Identifying and Eliminating the Source

The first step in managing vertigo from infrasound is to identify and minimize exposure to the source of infrasound. This may involve:

• Environmental Assessment: Conducting assessments to determine the levels of infrasound in specific environments, especially in occupational settings.
• Engineering Controls: Implementing soundproofing measures or relocating equipment that generates infrasound to reduce exposure for individuals in the vicinity[2].

2. Symptomatic Treatment

For patients experiencing vertigo symptoms, several symptomatic treatments can be employed:

• Vestibular Rehabilitation Therapy (VRT): This is a specialized form of physical therapy aimed at improving balance and reducing dizziness through exercises that promote vestibular compensation[3].
• Medications: Depending on the severity of symptoms, medications may be prescribed, including:
• Antihistamines (e.g., meclizine) to alleviate dizziness.
• Benzodiazepines (e.g., diazepam) for short-term relief of acute symptoms.
• Antiemetics (e.g., ondansetron) to manage nausea associated with vertigo[4].

3. Patient Education and Counseling

Educating patients about the nature of their condition and the potential triggers is crucial. Counseling may include:

• Lifestyle Modifications: Advising patients on strategies to avoid known triggers of infrasound exposure.
• Coping Strategies: Teaching relaxation techniques and coping mechanisms to manage anxiety related to vertigo episodes[5].

4. Follow-Up and Monitoring

Regular follow-up appointments are essential to monitor the patient's progress and adjust treatment plans as necessary. This may involve:

• Re-evaluating Symptoms: Assessing the frequency and intensity of vertigo episodes.
• Adjusting Treatment: Modifying medications or therapy based on the patient's response to initial treatments[6].

Conclusion

The management of vertigo from infrasound, as indicated by ICD-10 code T75.23, involves a multifaceted approach that includes identifying and mitigating exposure, symptomatic treatment, patient education, and ongoing monitoring. As research continues to evolve regarding the effects of infrasound on health, treatment protocols may be refined to enhance patient outcomes. If you or someone you know is experiencing symptoms of vertigo, consulting a healthcare professional for a tailored treatment plan is advisable.

References

1. Impairment of the Endothelium and Disorder of ...
2. Application of the International Classification of Diseases to ...
3. How to Code Vertigo And Its Treatments?
4. ICD-10-CM Diagnosis Code R42 - Dizziness and giddiness
5. Infrasound and low-frequency noise – does it affect human ...
6. 2024 QCDR Measure Specifications Publication File